BiotechTV

Daily biotech news, content, and exclusive interviews.

[BiotechTV @BiotechTV]

𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐒𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭: In this new BiotechTV series, we ask biotech founders what motivated them to start their companies. First up, we visit Mohit Sachdeva in Philly to hear the story behind Ajaya Bio, which is developing bispecifics. https://t.co/fCVoiwEbg7

[BiotechTV @BiotechTV]

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: At its R&D Day in London today, Gubra provided updates on obesity assets licensed to AbbVie and Boehringer Ingelheim, as well as highlighted its lead internal program UCN2.

Full video: https://t.co/TEZUHYx6c0

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐏𝐡𝐢𝐥𝐚𝐝𝐞𝐥𝐩𝐡𝐢𝐚: Earlier this month, @Agilent agreed to acquire Philadelphia based @Proscia, a provider of digital pathology software for clinical and life-sciences customers, for $240M up front and up to $30M more.

Full video: https://t.co/2B3ZyQsdRW

[BiotechTV @BiotechTV]

𝐖𝐞𝐞𝐤 𝐢𝐧 𝐑𝐞𝐯𝐢𝐞𝐰: Biotech had a small bounce this week, though clinical trial news mostly leaned towards the negative side.

$XBI $EYPT $AARD $IRON $GSK $MRNA $TNGX $EVAX

[BiotechTV @BiotechTV]

@tranbryannguyen @Mizuho @salimqsyed 💯

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: @Mizuho Senior Biotech Analyst @salimqsyed shares his take on biotech's current lull, and discusses companies he covers.

$XBI $RCUS $CYTK $BBIO $MAZE $IPSC

Full video: https://t.co/P1LateCa0Z

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: @Immuneering Co-Founder & CEO @BenZeskind discusses the future of the third generation MEK inhibitor atebimetinib, which has shown promising data in first line pancreatic cancer. $IMRX

Full video: https://t.co/9YdLBmSYWA

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: @BarclaysCIB Biotech Analyst Ellie Merle previews this weekend's highly anticipated cancer vaccine data from Merck and Moderna at ESMO. She sees scenarios for the stock ranging from $100 to mid $400's. $MRK $MRNA

Full video: https://t.co/5Jia8niCFk

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: Lexeo Therapeutics' CEO Nolan Townsend discusses a recent acquisition in Friedreich's ataxia and upcoming data in PKP2 arrhythmogenic cardiomyopathy. $LXEO

Full video: https://t.co/1kShbDgirT

[BiotechTV @BiotechTV]

𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: BiotechTV will be at the iconic @NYSE today. Watch for these interviews this afternoon. $LXEO $IMRX

[BiotechTV @BiotechTV]

𝐂𝐨𝐧𝐠𝐫𝐚𝐭𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐎𝐫𝐜𝐡𝐞𝐬𝐭𝐫𝐚: Congratulations to our sponsor and partner Orchestra - it was announced moments ago that they are being acquired by @OpenAI. Kudos to @ashokaraj_ and the entire Orchestra team!

[Brad Loncar @bradloncar]

I’m very happy for @ashokaraj_ and the Orchestra team. It has been an honor working with them this year as a sponsor partner to @BiotechTV, and learning from the best how AI and agents are transforming biopharma. Very smart move by @OpenAI!

[BiotechTV @BiotechTV]

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Penn spin-out Incuta Therapeutics is developing a long-lasting JAK inhibitor for hidradenitis suppurativa that is designed to concentrate at the site of the lesions.

Full video: https://t.co/1fUMXJYWZG

[BiotechTV @BiotechTV]

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐄𝐎 𝐒𝐢𝐬𝐭𝐞𝐫𝐡𝐨𝐨𝐝: Biotech company chair, director, and former CEO Paula Soteropoulos discusses learnings from her career and announces a new book she and her daughter wrote about women's health.

Watch the full discussion: https://t.co/4sj0Q6Wqvj

[BiotechTV @BiotechTV]

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: Episode 50 | @ThirdRockV's Bob Tepper describes working in biotech (Cell Genesys & Millennium) in the early days of the sector, and Third Rock's unique culture.

Watch the full episode: https://t.co/Lqft2MaunK

[BiotechTV @BiotechTV]

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: London based IMU Biosciences announced today that it will use its immune system profiling platform with 80,000 blood samples from UK Biobank to create a large-scale picture of the human immune system.

Full video: https://t.co/O8JLbBMoiY

[BiotechTV @BiotechTV]

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Nouscom announced a $135M series D raise this morning. It will help the company advance through a registration study its cancer vaccine that is meant to prevent the occurrence of Lynch Syndrome in genetic carriers.

[BiotechTV @BiotechTV]

𝐖𝐞𝐞𝐤 𝐢𝐧 𝐑𝐞𝐯𝐢𝐞𝐰: XBI was down over 6% this week.

$GUTS $CTNM $VTRS $IBRX $BNTX $ABBV

[BiotechTV @BiotechTV]

𝐍𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐲 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐃𝐚𝐲: @NrgTherapeutics recently announced the target of its lead ALS program, NLRX1. Co-Founder and CEO Neil Miller describes it and discusses neurology drug development.

[BiotechTV @BiotechTV]

𝐀𝐥𝐢𝐠𝐧 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟔: @generaloncology was born from a family's effort to come up with something new for a woman with pancreatic cancer.

Full video: https://t.co/qnsiaOydqi